Large‐scale computational identification of HIV T‐cell epitopes
暂无分享,去创建一个
[1] A. D. De Groot,et al. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. , 1997, AIDS research and human retroviruses.
[2] A. Tolstrup,et al. Functional screening of a retroviral peptide library for MHC class I presentation. , 2001, Gene.
[3] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[4] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[5] R. Phillips,et al. Patterns of Immunodominance in HIV-1–specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope Mutation , 1997, The Journal of experimental medicine.
[6] S. Rowland-Jones,et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. , 1998, The Journal of clinical investigation.
[7] Vladimir Brusic,et al. MHCPEP, a database of MHC-binding peptides: update 1996 , 1997, Nucleic Acids Res..
[8] Sean R. Eddy,et al. Profile hidden Markov models , 1998, Bioinform..
[9] W. Blattner,et al. Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences , 1999, Journal of Virology.
[10] H Mamitsuka,et al. Predicting peptides that bind to MHC molecules using supervised learning of hidden markov models , 1998, Proteins.
[11] Limsoon Wong,et al. FIMM, a database of functional molecular immunology , 2000, Nucleic Acids Res..
[12] P. Klenerman,et al. The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection , 1998, Journal of Molecular Medicine.
[13] K. Parker,et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.
[14] Michael A. Gonzalez,et al. From genome to vaccine: in silico predictions, ex vivo verification. , 2001, Vaccine.
[15] Mark Lindsey,et al. Complexity among constituents of the HLA-B*1501 peptide motif , 1998, Immunogenetics.
[16] John Sidney,et al. Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding Motif , 2001, Journal of Virology.
[17] C. Schönbach,et al. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues. , 1995, Journal of immunology.
[18] D. Flower,et al. Toward the quantitative prediction of T-cell epitopes: coMFA and coMSIA studies of peptides with affinity for the class I MHC molecule HLA-A*0201. , 2001, Journal of medicinal chemistry.
[19] J Zeleznikow,et al. Efficient discovery of immune response targets by cyclical refinement of QSAR models of peptide binding. , 2001, Journal of molecular graphics & modelling.
[20] R. Phillips,et al. Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides , 1997, European journal of immunology.
[21] M. McElrath,et al. CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition. , 2001, Immunology letters.
[22] P. Sharp,et al. Genetic diversity of HIV-1: the moving target. , 2000, AIDS.
[23] L C Harrison,et al. MHCPEP: a database of MHC-binding peptides. , 1994, Nucleic acids research.
[24] B. Walker,et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.
[25] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[26] N. Nathanson,et al. Biological considerations in the development of a human immunodeficiency virus vaccine. , 2000, The Journal of infectious diseases.
[27] S. H. van der Burg,et al. HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDS. , 1997, Journal of immunology.
[28] Edward C. Holmes,et al. Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.
[29] V. Brusic,et al. Neural network-based prediction of candidate T-cell epitopes , 1998, Nature Biotechnology.
[30] R. J. Stonier,et al. Complex Systems: Mechanism of Adaptation , 1994 .
[31] Steven M. Wolinsky,et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes , 2002, Nature.